Last reviewed · How we verify

NCT04681235

Virtual Reality Training Affects on Motor Functions and Mental Health in Stroke Patients

Completed NA Last updated 23 December 2020
What this trial tests

NA trial testing Training on VR in Stroke in 34 participants. Completed in 27 July 2020.

Timeline
1 October 2019
Primary endpoint
27 July 2020
27 July 2020

Quick facts

Lead sponsorFederal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment34
Start date1 October 2019
Primary completion27 July 2020
Estimated completion27 July 2020
Sites1 location across Russia

Drugs / interventions tested

Conditions studied

Sponsor

Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health

Who can join

Adults 30 to 79, any sex, with Stroke or Motor Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In our study, we tested the hypothesis of the safe effect applicability of motor training in the immersion high-tech polymodal VR system not only on the parameters of balance, gait, and motor status of the patient, but also on his cognitive functions and mental health in patients with a degree of disability no more than 3 points on a scale Rankin.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04681235.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing